161 related articles for article (PubMed ID: 1324528)
1. Intravenous immunoglobulin: use in pediatric bone marrow transplantation.
Casper JT; Sedmak G; Harris RE; Carrigan DR; Baxter-Lowe LA; Ash RC
Semin Hematol; 1992 Jul; 29(3 Suppl 2):100-5. PubMed ID: 1324528
[No Abstract] [Full Text] [Related]
2. Risk factors for cytomegalovirus pneumonia following allogeneic bone marrow transplantation after prophylaxis with intravenous immunoglobulin.
Krischer J; Elfenbein G; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
Semin Hematol; 1992 Jul; 29(3 Suppl 2):89-95. PubMed ID: 1324530
[No Abstract] [Full Text] [Related]
3. Alternate applications of immunoglobulin following bone marrow transplantation.
Copelan EA; Avalos BR; Kapoor N; Bechtel T; Tutschka PJ
Semin Hematol; 1992 Jul; 29(3 Suppl 2):96-9. PubMed ID: 1324531
[No Abstract] [Full Text] [Related]
4. Randomized double-blinded comparison of three intravenous immunoglobulin products in bone marrow transplantation.
Peltier MK; Filipovich AH; Bechtel M; Dirksen CL; Englund JA
Semin Hematol; 1992 Jul; 29(3 Suppl 2):112-5. PubMed ID: 1324529
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin and CMV-seronegative blood products for prevention of CMV infection and disease in bone marrow transplant recipients.
Winston DJ; Ho WG; Bartoni K; Champlin RE
Bone Marrow Transplant; 1993 Sep; 12(3):283-8. PubMed ID: 8241988
[TBL] [Abstract][Full Text] [Related]
6. Infections in allogeneic bone marrow transplant recipients.
Wingard JR
Semin Oncol; 1993 Oct; 20(5 Suppl 6):80-7. PubMed ID: 8211220
[TBL] [Abstract][Full Text] [Related]
7. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
[TBL] [Abstract][Full Text] [Related]
8. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
[TBL] [Abstract][Full Text] [Related]
9. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
Cottler-Fox M; Lynch M; Pickle LW; Cahill R; Spitzer TR; Deeg HJ
Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus infection in bone marrow transplant recipients: use of intravenous gamma globulin as a prophylactic and therapeutic agent.
Kapoor N; Copelan EA; Tutschka PJ
Transplant Proc; 1989 Feb; 21(1 Pt 3):3095-6. PubMed ID: 2539686
[No Abstract] [Full Text] [Related]
11. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
[TBL] [Abstract][Full Text] [Related]
12. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
Condie RM; O'Reilly RJ
Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
[No Abstract] [Full Text] [Related]
13. Interim results of a multicenter trial to prevent cytomegalovirus pneumonia after allogeneic bone marrow transplantation.
Elfenbein G; Krischer J; Babington R; Hong R; Jansen J; Lazarus H; Winton E; Rand K
Transplant Proc; 1989 Feb; 21(1 Pt 3):3099-100. PubMed ID: 2539688
[No Abstract] [Full Text] [Related]
14. Incidence of infection and acute rejection after cytomegalovirus immune globulin prophylaxis in renal transplantation.
Basadonna G; Feria A; Perez R; Klein H; Sturges M; Colquhoun S
Transplant Proc; 1994 Oct; 26(5 Suppl 1):52-3. PubMed ID: 7940976
[No Abstract] [Full Text] [Related]
15. Prophylactic use of immunoglobulin in bone marrow transplantation.
Ho WG; Winston DJ; Champlin RE; Gale RP
Int J Cell Cloning; 1986; 4 Suppl 1():174-80. PubMed ID: 3018101
[No Abstract] [Full Text] [Related]
16. Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation.
Spitzer TR; Cottler-Fox M; Sullivan P; Lynch M; Tefft MC; Pickle LW; Cirenza E; Cahill R; Deeg HJ; Sacher R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):123-6. PubMed ID: 1509292
[No Abstract] [Full Text] [Related]
17. Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease.
Conti DJ; Freed BM; Lempert N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1421-2. PubMed ID: 8382867
[No Abstract] [Full Text] [Related]
18. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation.
Miyamura K; Takeyama K; Kojima S; Minami S; Matsuyama K; Morishima Y; Kodera Y
Bone Marrow Transplant; 1989 Sep; 4(5):533-5. PubMed ID: 2551434
[TBL] [Abstract][Full Text] [Related]
19. The role of immunoglobulin in bone marrow transplantation.
Saral R
Transplant Proc; 1991 Aug; 23(4):2128-32. PubMed ID: 1871829
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation: a meta-analysis.
Messori A; Rampazzo R; Scroccaro G; Martini N
Bone Marrow Transplant; 1994 Feb; 13(2):163-7. PubMed ID: 8205085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
